JSLL vs SAKAR: Stock Comparison
JEENA SIKHO LIFECARE is the larger company by market capitalisation. JEENA SIKHO LIFECARE shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
JSLL leads 9; SAKAR leads 4 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | JSLL | SAKAR |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceuticals | Pharmaceuticals |
Price
| Metric | JSLL | SAKAR |
|---|---|---|
| Live Price | ₹322.3 | ₹975.55 |
| Day Change | -6.65% | -3.97% |
| Volume | 11.36 L | 86,756 |
| 52-Week High | ₹835 | ₹1,229.85 |
| 52-Week Low | ₹326 | ₹352.5 |
| Distance from 52W High | -61.4% | -20.68% |
Valuation
| Metric | JSLL | SAKAR |
|---|---|---|
| Market Cap | ₹4,022 Cr | ₹2,169 Cr |
| P/E Ratio | 16.94x | 50.6x |
| P/B Ratio | 8.58x | 6.27x |
| EPS | ₹5.31 | ₹5.08 |
| Book Value | ₹37.57 | ₹128.3 |
| Dividend Yield | 1.39% | 0% |
Growth
| Metric | JSLL | SAKAR |
|---|---|---|
| Revenue Growth (TTM YoY) | 54.8% | 40.1% |
| EPS Growth (TTM YoY) | 77.5% | 87.2% |
| Qtr Sales Growth | 0% | 19.79% |
| Qtr Profit Growth | 0% | 9.94% |
Profitability & Leverage
| Metric | JSLL | SAKAR |
|---|---|---|
| ROE | 47.48% | 10.68% |
| ROCE | 50.64% | 10.13% |
| Net Margin | 27.68% | 12.11% |
| Operating Margin | 38.71% | 18.91% |
| Debt to Equity | 0x | 0.26x |
Shareholding
As of Sep 2026 • change vs previous quarter| Metric | JSLL | SAKAR |
|---|---|---|
| Promoter Holding | 63.67%▲ 0.05 pp | 51.7%▼ 0.82 pp |
| FII Holding | 4.5%▼ 0.28 pp | 12.34%▲ 0.21 pp |
| DII Holding | 0.53%▲ 0.17 pp | 11.92%▲ 0.55 pp |
| Public Holding | 31.3%▲ 0.07 pp | 24.04%▲ 0.06 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: JEENA SIKHO LIFECARE and SAKAR HEALTHCARE.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.